TrialPinks share price this year I feel will heavily weigh on the outcome of the trial being conducted. I'm highly confident that the results of the trial will be positive. Getting FDA approval for their AI technology will rely on this study and sales team will have a far easier job selling their product with this approval. Let's hope 2023 is better than 2022 for perimeter. Let's get the FDA approval and get listed on the Nasdaq!